261 related articles for article (PubMed ID: 36209227)
1. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
[TBL] [Abstract][Full Text] [Related]
2. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
[TBL] [Abstract][Full Text] [Related]
3. Safer opioid supply: qualitative program evaluation.
Haines M; O'Byrne P
Harm Reduct J; 2023 Apr; 20(1):53. PubMed ID: 37081500
[TBL] [Abstract][Full Text] [Related]
4. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis.
Karamouzian M; Rafat B; Kolla G; Urbanoski K; Atkinson K; Bardwell G; Bonn M; Touesnard N; Henderson N; Bowles J; Boyd J; Brunelle C; Eeuwes J; Fikowski J; Gomes T; Guta A; Hyshka E; Ivsins A; Kennedy MC; Laurence G; Martignetti L; Nafeh F; Salters K; Tu D; Strike C; Pauly B; Werb D
Int J Drug Policy; 2023 Oct; 120():104157. PubMed ID: 37574645
[TBL] [Abstract][Full Text] [Related]
5. "If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis.
Kolla G; Pauly B; Cameron F; Hobbs H; Ranger C; McCall J; Majalahti J; Toombs K; LeMaistre J; Selfridge M; Urbanoski K
Harm Reduct J; 2024 Jun; 21(1):111. PubMed ID: 38849866
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
Palis H; Haywood B; McDougall J; Xavier CG; Desai R; Tobias S; Burgess H; Ferguson M; Liu L; Kinniburgh B; Slaunwhite AK; Crabtree A; Buxton JA
Harm Reduct J; 2024 Jan; 21(1):5. PubMed ID: 38184576
[TBL] [Abstract][Full Text] [Related]
7. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
[TBL] [Abstract][Full Text] [Related]
8. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
9. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
Bardwell G; Bowles JM; Mansoor M; Werb D; Kerr T
Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):14. PubMed ID: 36869358
[TBL] [Abstract][Full Text] [Related]
10. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
[TBL] [Abstract][Full Text] [Related]
11. Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation.
McCall J; Hobbs H; Ranger C; Cameron F; Stuart H; Nelken J; Majalahti J; Urbanoski K; Kolla G; LeMaistre J; Toombs K; Herriot R; Pauly B
Subst Abuse Treat Prev Policy; 2024 Mar; 19(1):19. PubMed ID: 38444035
[TBL] [Abstract][Full Text] [Related]
12. Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.
Pauly BB; Kurz M; Dale LM; Macevicius C; Kalicum J; Pérez DG; McCall J; Urbanoski K; Barker B; Slaunwhite A; Lindsay M; Nosyk B
J Subst Use Addict Treat; 2024 Jun; 161():209341. PubMed ID: 38490334
[TBL] [Abstract][Full Text] [Related]
13. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
Wallace B; van Roode T; Pagan F; Hore D; Pauly B
BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
[TBL] [Abstract][Full Text] [Related]
14. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
Kolla G; Tarannum CN; Fajber K; Worku F; Norris K; Long C; Fagundes R; Rucchetto A; Hannan E; Kikot R; Klaiman M; Firestone M; Bayoumi A; Laurence G; Hayman K
Harm Reduct J; 2024 Jan; 21(1):17. PubMed ID: 38243267
[TBL] [Abstract][Full Text] [Related]
15. Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study.
Coulaud PJ; Chayama KL; Schwartz C; Purdie A; Lysyshyn M; Ti L; Knight R
Harm Reduct J; 2024 Apr; 21(1):87. PubMed ID: 38678256
[TBL] [Abstract][Full Text] [Related]
16. Mapping a moral panic: News media narratives and medical expertise in public debates on safer supply, diversion, and youth drug use in Canada.
Michaud L; Kolla G; Rudzinski K; Guta A
Int J Drug Policy; 2024 May; 127():104423. PubMed ID: 38642543
[TBL] [Abstract][Full Text] [Related]
17. "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
Glegg S; McCrae K; Kolla G; Touesnard N; Turnbull J; Brothers TD; Brar R; Sutherland C; Le Foll B; Sereda A; Goyer MÈ; Rai N; Bernstein S; Fairbairn N
Int J Drug Policy; 2022 Aug; 106():103742. PubMed ID: 35679695
[TBL] [Abstract][Full Text] [Related]
18. Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada.
Gagnon M; Rudzinski K; Guta A; Schmidt RA; Kryszajtys DT; Kolla G; Strike C
Harm Reduct J; 2023 Jun; 20(1):81. PubMed ID: 37380995
[TBL] [Abstract][Full Text] [Related]
19. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
[TBL] [Abstract][Full Text] [Related]
20. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
